These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10084469)

  • 21. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
    Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term cardiovascular effects of salmeterol.
    Tranfa CM; Pelaia G; Grembiale RD; Naty S; Durante S; Borrello G
    Chest; 1998 May; 113(5):1272-6. PubMed ID: 9596305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma.
    Langton Hewer S; Hobbs J; French D; Lenney W
    Respir Med; 1995 Jul; 89(6):435-40. PubMed ID: 7644775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.
    Castle W; Fuller R; Hall J; Palmer J
    BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
    Bronsky EA; Pearlman DS; Pobiner BF; Scott C; Wang Y; Stahl E
    Pediatrics; 1999 Sep; 104(3 Pt 1):501-6. PubMed ID: 10469776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of salmeterol in nonspecialist practice settings.
    D'Urzo AD; Chapman KR; Cartier A; Hargreave FE; Fitzgerald M; Tesarowski D
    Chest; 2001 Mar; 119(3):714-9. PubMed ID: 11243947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
    BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
    BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.
    Kraft M; Wenzel SE; Bettinger CM; Martin RJ
    Chest; 1997 May; 111(5):1249-54. PubMed ID: 9149578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.